title: Managing epilepsy in general practice: the dissemination and uptake of a free audit package, and collated results from 12 practices in England and Wales.
abstract: This study aimed to assess the uptake and use by general practitioners of a free epilepsy audit protocol, and describe the care provided by practices which returned completed audits. A protocol for epilepsy audit in general practice was designed and described in the medical press. Practices were invited to reply. Responders were provided with the protocol. A total of 215 practices responded to the articles in the press. Questionnaires asking how they had used the audit protocol were sent to them 18 months later. One hundred and seventy (79%) of the 215 responding practices returned the questionnaires. Forty-seven (28%) had collected some or all of the data. Twenty-two (13%) submitted data of which 12 (7%) matched the original protocol. Aggregated list sizes for these 12 practices was 75689 and 502 (0.66%) patients were being treated. Of these, 60% were seizure free and 11% were having more than one seizure per month. Seventy-one were receiving monotherapy and only two patients were taking more than three drugs. Eighty-eight per cent of patients still having seizures had been seen by their GP for their epilepsy in the last 12 months. In 18% of cases, information on epilepsy lifestyle issues had been given and noted. Offering a free epilepsy audit package can stimulate interest amongst practices in the topic and resulted in 13% collecting and submitting their data for analysis. Practices reported a higher prevalence for epilepsy (0.66%) than in previous studies. The majority of patients with active epilepsy (88%) had been seen by a general practitioner in the last 12 months. Most (71%) were receiving monotherapy, but recording of seizure frequency and provision of information about epilepsy was low.
authors.affiliation: Department of Neurology, York District Hospital, UK.
authors.forename: B
authors.initials: B
authors.lastname: Chappell
authors.forename: W W
authors.initials: WW
authors.lastname: Hall
mesh_terms: D000927:Anticonvulsants / Q000008:administration & dosage* / Q000009:adverse effects; D003430:Cross-Sectional Studies; D003625:Data Collection; D004359:Drug Therapy, Combination; D004363:Drug Utilization; D004569:Electroencephalography / Q000187:drug effects; D004739:England / Q000453:epidemiology; D004827:Epilepsy / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D005194:Family Practice / Q000706:statistics & numerical data; D006801:Humans; D015994:Incidence; D008485:Medical Audit / Q000706:statistics & numerical data*; D010348:Patient Care Team / Q000706:statistics & numerical data*; D011788:Quality of Life; D014852:Wales / Q000453:epidemiology
chemical_list: D000927:Anticonvulsants